Clinical Trial Update: A Study of JNJ-40346527 in Patients With Active Rheumatoid Arthritis Despite Disease-modifying Antirheumatic Drug Therapy [Phase 2]

View source ↗

Summary

This update covers a Phase 2 clinical trial evaluating JNJ-40346527 in patients with active rheumatoid arthritis who do not respond adequately to DMARD therapy,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• JNJ-40346527

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Arthritis, Rheumatoid | Phase 2 | Status: COMPLETED